Literature DB >> 10359298

Mycobacterium ulcerans--a mini-review.

P D R Johnson1, T P Stinear1, J A Hayan2.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10359298     DOI： 10.1099/00222615-48-6-511

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN： 0022-2615            Impact factor:   2.472


× No keyword cloud information.
  16 in total

Review 1.  Treating Mycobacterium ulcerans disease (Buruli ulcer): from surgery to antibiotics, is the pill mightier than the knife?

Authors:  Paul J Converse; Eric L Nuermberger; Deepak V Almeida; Jacques H Grosset
Journal:  Future Microbiol       Date:  2011-10       Impact factor: 3.165

2.  Buruli ulcer in Malawi - a first report.

Authors:  O O Komolafe
Journal:  Malawi Med J       Date:  2001-09       Impact factor: 0.875

3.  Infection with Mycobacterium ulcerans induces persistent inflammatory responses in mice.

Authors:  Martinha S Oliveira; Alexandra G Fraga; Egídio Torrado; António G Castro; João P Pereira; Adhemar Longatto Filho; Fernanda Milanezi; Fernando C Schmitt; Wayne M Meyers; Françoise Portaels; Manuel T Silva; Jorge Pedrosa
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

4.  Evidence for an intramacrophage growth phase of Mycobacterium ulcerans.

Authors:  Egídio Torrado; Alexandra G Fraga; António G Castro; Pieter Stragier; Wayne M Meyers; Françoise Portaels; Manuel T Silva; Jorge Pedrosa
Journal:  Infect Immun       Date:  2006-12-04       Impact factor: 3.441

Review 5.  Buruli Ulcer, a Prototype for Ecosystem-Related Infection, Caused by Mycobacterium ulcerans.

Authors:  Dezemon Zingue; Amar Bouam; Roger B D Tian; Michel Drancourt
Journal:  Clin Microbiol Rev       Date:  2017-12-13       Impact factor: 26.132

6.  Comparative genetic analysis of Mycobacterium ulcerans and Mycobacterium marinum reveals evidence of recent divergence.

Authors:  T P Stinear; G A Jenkin; P D Johnson; J K Davies
Journal:  J Bacteriol       Date:  2000-11       Impact factor: 3.490

7.  Protective efficacy of a DNA vaccine encoding antigen 85A from Mycobacterium bovis BCG against Buruli ulcer.

Authors:  A Tanghe; J Content; J P Van Vooren; F Portaels; K Huygen
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

8.  Biochemical and genetic evidence for phospholipase C activity in Mycobacterium ulcerans.

Authors:  A Gomez; A Mve-Obiang; B Vray; J Remacle; K Chemlal; W M Meyers; F Portaels; P A Fonteyne
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

9.  Detection of phospholipase C in nontuberculous mycobacteria and its possible role in hemolytic activity.

Authors:  A Gomez; A Mve-Obiang; B Vray; W Rudnicka; I C Shamputa; F Portaels; W M Meyers; P A Fonteyne; L Realini
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

10.  A Landscape-based model for predicting Mycobacterium ulcerans infection (Buruli Ulcer disease) presence in Benin, West Africa.

Authors:  Tyler Wagner; M Eric Benbow; Meghan Burns; R Christian Johnson; Richard W Merritt; Jiaguo Qi; Pamela L C Small
Journal:  Ecohealth       Date:  2008-02-08       Impact factor: 3.184
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.